1 / 20

Malattie Autoimmuni

Malattie Autoimmuni. Rappresentano ancora oggi uno dei problemi più spinosi dell’immunologia, sia sul piano sperimentale che su quello clinico. Le conoscenze attuali sui meccanismi coinvolti sono ancora incomplete e di conseguenza l’eziologia è spesso ignota.

content
Download Presentation

Malattie Autoimmuni

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MalattieAutoimmuni • Rappresentano ancora oggi uno dei problemi più spinosi • dell’immunologia, sia sul piano sperimentale che su quello • clinico. • Le conoscenze attuali sui meccanismi coinvolti sono ancora • incomplete e di conseguenza l’eziologia è spesso ignota. • Inoltre sono per lo più malattie multifattoriali, in quanto nella • loro patogenesi intervengono fattori di predisposizione genetica • e fattori ambientali.

  2. Manifestazioni Autoimmuni Diabete mellito di tipo I Tiroidite Anemia emolitica Enteropatia Dermatite • Alopecia

  3. CD4+ CD25+ Regulatory T cells The immune system Protection from microorganisms Tolerance to the SELF

  4. Delezione clonale (interazione Fas e Fas-L) Anergia clonale Attività delle T regolatorie Principali meccanismi di eliminazione (periferici) di linfociti autoreattivi Indifferenza clonale

  5. Generazione delle Treg Il timo produce la maggior parte delle Treg CD4+CD25+, (5-10% linfociti CD4+T circolanti) come sottopopolazione distinta e funzionalmente matura Lo sviluppo di T reg puo’ avvenire a partire da cellule convenzionali, sotto specifiche condizioni di attivazione

  6. suppressing the proliferation or function • of autoreactive T cells • possibility that Treg cells may play a central role in immune homeostasis • and regulation of immune responses toward foreign antigens CD4+ CD25+ Regulatory T cells in the immune system • maintenance of immunological • self-tolerance

  7. Sindrome X-linked recessiva • Mortalità elevata entro il primo anno di vita. CASO CLINICO IPEX: Immune Dysregulation, Polyendocrinopathy, Entheropathy, X-linked. → Patologia da difetto della tolleranza immune.

  8. Presents most commonly in early childhood: • IDDM • Severe enteropathy • Skin disorders • Variable autoimmune • phenomena Autoantibodies against: Thyroid Kidney Pancreatic islets Small Intestine Platelets and others CD4+CD25+ Regulatory T cells are involved in I P E X mmune dysregulation olyendocrinopathy nteropathy -linked

  9. FoxP3 in regulatory T cells C NFAT and NF-kappaB (nuclear factors) C blocks their ability to induce the endogenous expression of their target genes, including key cytokine genes • Foxp3 is a regulatory T cell-specific transcriptional factor – FKH family • master regulator of the development and function of regulatory T cells As trascrptional factor: • Probably regulates/suppresses cytokine expression

  10. FOXP3 as proteic product N C PRR Zn FKH 1 2 3 • 11 esoni – 431 aa • functional domains: • Proline rich region in N-terminal zone • Zinc finger domain • Forkhead winged-helyx domain: necessary of DNA-binding and nuclear location

  11. Human IPEX: 13 mutations identified until now  • In the FKH domain • in leucine zipper domain • removing of stop codon  products with C-terminal extensions Every patient with these mutations has classic IPEX, and symptomatic differences are unremarkable

  12. Molecular and proteomical study 1 . Identification and estimation of FOXP3 expression 2 .Identification and estimation of other important and related genes expression 3 . Identification of specific protein-protein interactions of FOXP3 and its different domains

  13. Steps of the study Recombinant protein Tagged products Cloning of FoxP3 gene and its domains N PRR Zn FKH C 1 2 3 Cloning into expression vector

  14.  pTrcHis  Production in  Purification bacterial cells by His Tag Recombinant  protein  Policlonal sera Expression of FoxP3 in procariotic cells

  15. Expression in culture cells: - HEK293 - T lymphocytes (if possible) Expression of FoxP3 in eukaryotic cells Cloning of FoxP3 in fusion with GFP - N-terminal with StrepTag - C-terminal FoxP3/Dom GFP FoxP3/Dom TAG

  16. MICROSCOPY  Confocal  Detection of GFP Use of anti-His (or anti-GFP) antibodies on  Nuclear extracts  Cytoplasmatic extracts Localization of FoxP3 Under different conditions of stimulation

  17. FOXP3 interactions • Characterization of co-precipitated proteins (mass spectrophotometry…) • Immunoprecipitation of FoxP3 with anti-TAG (anti-His / anti-GFP / Strep-Tag vs Strep-Tactin)

  18. Interagent molecule 2D SDS-PAGE IEF detection Mass spectometry identification

  19. FOXP3 interactions Use of Bacterial Two-Hybrid System • Easy in vivo screening and selection offunctioninteractions between two proteins • Analysis of different cDNA libraries of T cells subpopulations under different conditions of stimulation • Informations about methabolic pathways in which FoxP3 is involved

More Related